EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluating the Longitudinal Association of Rheumatoid Arthritis Disease Activity With Phenotypic Frailty: Evidence for Secondary Frailty?

Hannah F Brubeck iD, Kylie E Riggles, Riley S Bass, Elizabeth R Wahl, George Mount, Dolores M Shoback, James S Andrews, Jose M Garcia, Ariela R Orkaby, Joshua F Baker, Patricia P Katz iD, Katherine D Wysham und 1 weitere

Arthritis Care & Research · 2026

DOI: 10.1002/acr.25615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis Care & Research, 2026. Verfasst von Hannah F Brubeck und 12 weiteren Autor:innen. Beteiligte Einrichtung: VA Puget Sound Health Care System, Seattle, Washington. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Frailty. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, BLRD VA, RRD VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The cross‐sectional association between rheumatoid arthritis (RA) disease activity and frailty has been described; however, the longitudinal relationship is less well understood. We evaluated the association between disease activity and frailty over time.

Methods

We used a longitudinal RA cohort established at the Department of Veterans Affairs Puget Sound Health Care System. RA disease activity (Disease Activity Score in 28 joints using the C‐reactive protein level [DAS28‐CRP]) and frailty (measured by the Fried Frailty Phenotype [FFP]) were evaluated at baseline and at one year. Frailty was categorized as robust, prefrail, or frail. Ordinal logistic regressions assessed the cross‐sectional associations of DAS28‐CRP and frailty at baseline and at one year. Paired t ‐tests and multivariable mixed ordinal logistic regressions assessed the longitudinal associations of DAS28‐CRP and frailty. Models were adjusted for age, sex, disease duration, prednisone use, conventional synthetic disease‐modifying antirheumatic drug (DMARD) use, and biologic DMARD use.

Results

A total of 132 patients with RA aged 64.2 ± 11.3 years were included; 73% were male, 69% were White, 11% were Black, and 12% reported multiple races. The mean ± SD baseline DAS28‐CRP was 3.9 ± 1.3, and frailty was categorized as robust in 35 (27%) patients, prefrail in 77 (58%) patients, and frail in 20 (15%) patients. DAS28‐CRP (per 1‐unit increase) was associated with a higher FFP category at baseline (adjusted odds ratio [aOR] 1.98, P < 0.0001). Disease activity increased in those whose frailty score worsened at one year (mean ± SD change score 0.61 ± 0.96, P = 0.0121). An increased DAS28‐CRP was independently associated with a higher frailty category over one year (aOR 3.31, P < 0.0001; n = 65).

Conclusion

Disease activity is independently associated with phenotypic frailty. Increased disease activity over time is associated with worsening frailty status. Future studies are needed to explore this longitudinal relationship and to determine if controlling disease activity can mitigate frailty.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidFrailtyHumansMaleFemaleMiddle AgedAgedLongitudinal StudiesPhenotypeSeverity of Illness IndexCross-Sectional StudiesAntirheumatic AgentsC-Reactive Protein

Substanzen

Antirheumatic AgentsC-Reactive Protein

Autor:innen und Institutionen

  • VA Puget Sound Health Care System, Seattle, Washington.
  • VA Puget Sound Health Care System and University of Washington, Seattle, Washington.
  • San Francisco VA Medical Center and University of California San Francisco, San Francisco, California.
  • University of Alabama at Birmingham, Birmingham VA Health Care System, and Atlanta-Birmingham VA Geriatric Research Education and Clinical Center, Birmingham, Alabama.
  • VA Puget Sound Health Care System, Puget Sound Geriatric Research Education and Clinical Center, and University of Washington, Seattle, Washington.
  • New England Geriatric Research, Education, and Clinical Center, VA Boston Healthcare System, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Hannah F Brubeck, Patricia P Katz, Courtney N Loecker

Förderung

  • NCI NIH HHS
  • BLRD VA
  • RRD VA
  • CSRD VA
  • NIA NIH HHS
  • U.S. Department of Veterans Affairs

Zitieren

APA

Brubeck, H. F., Riggles, K. E., Bass, R. S., Wahl, E. R., Mount, G., Shoback, D. M., Andrews, J. S., Garcia, J. M., Orkaby, A. R., Baker, J. F., Katz, P. P., Wysham, K. D., & Loecker, C. N. (2026). Evaluating the Longitudinal Association of Rheumatoid Arthritis Disease Activity With Phenotypic Frailty: Evidence for Secondary Frailty?. Arthritis Care & Research. https://doi.org/10.1002/acr.25615

Vancouver

Brubeck HF, Riggles KE, Bass RS, Wahl ER, Mount G, Shoback DM, et al. Evaluating the Longitudinal Association of Rheumatoid Arthritis Disease Activity With Phenotypic Frailty: Evidence for Secondary Frailty?. Arthritis Care & Research. 2026. doi:10.1002/acr.25615

BibTeX
@article{Brubeck2026,
  author = {Brubeck, Hannah F and Riggles, Kylie E and Bass, Riley S and Wahl, Elizabeth R and Mount, George and Shoback, Dolores M and Andrews, James S and Garcia, Jose M and Orkaby, Ariela R and Baker, Joshua F and Katz, Patricia P and Wysham, Katherine D and Loecker, Courtney N},
  title = {Evaluating the Longitudinal Association of Rheumatoid Arthritis Disease Activity With Phenotypic Frailty: Evidence for Secondary Frailty?},
  journal = {Arthritis Care & Research},
  year = {2026},
  doi = {10.1002/acr.25615}
}
Kostenlos starten →